NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

ex,

Thanks for more legal analysis, but I don’t think that you’re an attorney. 😶

The one aspect of your post that I can appreciate is that you have highlighted combos. Currently, DCVax-L combo research is being funded by the NIH. Merck, Oncovir, and the Phase One Foundation are also supporting the PD1 study at UCLA.

Combo is King.

https://clinicaltrials.gov/study/NCT04201873

I had to consult the detector after looking over your irresponsible legal commentary …




“This legal analysis is unreliable. The statement about the 6190030 patent and its related applications contains several speculative and technical assertions that require specific legal and patent expertise to verify. It discusses details about the prosecution of different versions of a patent, including their scope, claims, and status with the USPTO. The claim that one application was broader and another restricted in scope due to specific claims, and assertions about the potential market impact of these patents are complex and depend on detailed legal analysis. Without access to the actual patent documents and legal expertise in patent law, the author cannot provide a reliable assessment. For precise and authoritative information, it would be necessary to consult the USPTO database directly or seek advice from a patent attorney.”



https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html